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Infectious salmon anemia (ISA) is an emerging disease in farmed Atlantic salmon with important commercial conse-
quences. The pathogenicity of the ISA virus (ISAV; an orthomyxovirus) varies, observed as differences in disease develop-
ment and clinical signs. A small polymorphic region (PR) in the ISAV genomic segment encoding the hemagglutinin (HA) has
been described. An analysis of 33 HA gene sequences from historical and recent ISA outbreaks was performed, added to
a selection of previously published HA sequences. A differential deletion model explaining the generation of HA polymor-
phism is proposed. The European ISAV sequences could be grouped according to deletion patterns in PR. Cell-culture
replication and cytopathic effect varied between viruses from different PR groups. A rather complex epidemiology is
suggested, as (a) HA sequences representing several PR variants were detected in three samples; (b) identical mutations
occurred in different genetic lineages; and (c) large genetic differences were present in closely related viruses. © 2002 ElsevierKey Words: infectious salmon anemia virus; ISAV; ISA; h
INTRODUCTION
Infectious salmon anemia (ISA) is an economically
important disease for the Atlantic salmon (Salmo salar L.)
farming industry. Originally identified in Norway (Thorud
and Djupvik, 1988), ISA was verified in Canada in 1997
(Lovely et al., 1999), in Scotland in 1998 (Rodger et al.,
1998), and in the U.S.A. in 2001 (Bouchard et al., 2001).
Estimated mortality is between 15 and 100%, with older
fish exhibiting lower mortality than the younger ones.
Whereas ISA outbreaks have only been described in
Atlantic salmon (S. salar L.), the virus may, under exper-
imental conditions, persist and replicate in other salmo-
nids (Nylund et al., 1995, 1997; Nylund and Jakobsen,
1995; Rolland and Nylund, 1998), and there is increasing
evidence for the existence of ISAV in wild salmonid and
nonsalmonid fish (Raynard et al., 2001).
Infectious salmon anemia virus (ISAV) closely resem-
bles members of the Orthomyxoviridae (Falk et al., 1997;
Mjaaland et al., 1997; O’Halloran et al., 1999; Eliassen et
al., 2000; Sandvik et al., 2000; Hovland et al., 1994; Rim-
stad et al., 2001; Krossoy et al., 2001). However, while
consisting of eight single-stranded RNA segments of
negative polarity (Mjaaland et al., 1997), as influenza
1 To whom correspondence and reprint requests should be ad-
dressed at Norwegian School of Veterinary Science, P.O. Box 8146lutinin; HA; polymorphism.
virus A and B, the published sequences of the genomic
segments encoding the hemagglutinin (HA) (Rimstad et
al., 2001; Krossoy et al., 2001), the nucleoprotein (NP)
(Snow and Cunningham, 2001), and proteins with un-
known function (Mjaaland et al., 1997) show little
(Kibenge et al., 2001) or no apparent homologies of
nucleotide or deduced amino acid sequences to other
orthomyxoviruses. The genomic discrepancy is sup-
ported by significant difference in ISAV proteins com-
pared to influenza virus proteins, i.e., the 38–43-kDa
molecular size of the ISAV HA (Falk et al., 1997; Kibenge
et al., 2000; Rimstad et al., 2001; Griffiths et al., 2001) vs
the 59–61 kDa of influenza A virus HA (Steinhauer and
Wharton, 1998). Structural differences between the sur-
face proteins have been verified by electron microscopy
(Falk et al., 1997).
The key functions of influenza virus HA in virus repli-
cation are (1) host cell recognition and attachment, and
(2) penetration into the cell. Similar to influenza viruses,
ISAV recognizes and attaches to cell-surface receptors
terminating in sialic acid, and the fusion between virus
and cell membrane takes place in the acidic environment
of endosomes (Eliassen et al., 2000). Proteolytic cleav-
age of the HA molecule, giving rise to two disulfide-
linked chains (HA1 and HA2), is required for influenza
virus to be infectious. Similarly, trypsin treatment of ISAV
before cell-culture infection increases infectivity, indicat-Science (USA)
Dep., N-0033 Oslo, Norway. Fax:  47 2296 4818. E-mail:
siri.mjaaland@veths.no.
Virology 304, 379–391 (2002)
doi:10.1006/viro.2002.1658ing that cleavage of surface molecules stimulates virus
infectivity (Eliassen et al., 2000).© 2002 Elsevier Science (USA)
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Different courses of disease development in ISA out-
breaks have been observed (K. Thorud, personal obser-
vation), as well as differences in ISAV in vitro replication
characteristics (Kibenge et al., 2000; Bouchard et al.,
1999). Furthermore, histopathological changes may vary
between different outbreaks of ISA (Lovely et al., 1999;
Bouchard et al., 1999; Mullins et al., 1998). In the glyco-
sylated ISAV surface protein of 38–40 kDa isolated from
outbreaks in eastern Canada, the variation in molecule
size was linked to cell-line permissiveness (Griffiths et
al., 2001). Genetic variation in ISAV HA is thus indicated
and could be involved in the differences in natural ISA
outbreaks and cell-culture replication properties.
Sequence analysis of the HA gene (Rimstad et al.,
2001; Krossoy et al., 2001; Devold et al., 2001), and the
possible association between genetic variation in the HA
gene and antigenic variation between different ISAV iso-
lates (Griffiths et al., 2001; Dannevig et al., 1993), have
been reported. These reports indicate that there is a
major difference between the Canadian and European
isolates. However, while the differences between the
Canadian and European isolates are evenly spread
throughout the sequence, the variable region provides
most of the variation among the European isolates (Kros-
soy et al., 2001). In the present study we have extended
these data. Nucleotide sequence data from Norwegian
historical and recent ISA-derived material is correlated
with published European and Canadian ISAV sequence
data. Our sequence data are furthermore correlated with
disease development and in vitro virus replication prop-
erties. A model for the generation of the observed HA
molecule polymorphism is proposed, and its possible
role as a determinant for virulence is discussed.
RESULTS
Nucleotide and amino acid sequence alignments of
the full-length hemagglutinin ORF showed pairwise nu-
cleotide identities in the range of 94.8–97.2%, and amino
acid similarities between 96.5 and 97.6%, compared to
the Glesvaer strain. In the region located between nu-
cleotides 1021–1060 / amino acids 339–350 extensive
polymorphism was observed. This polymorphic region
(PR) could be defined primarily by the presence of gaps
and not by elevated occurrence of point mutations.
Whereas single-residue substitutions appeared to be no
more frequent than elsewhere in the HA gene, the intro-
duction of gaps in every sequence proved necessary to
align the sequences, indicating multiple deletions or
insertions. Also, as similar HA genes were found in
original sample materials, the observed differences were
unlikely to have arisen during adaptation to tissue cul-
ture.
The European sequences could be sorted into two
major groups, according to the presence of two different
“signature” sequence motifs (Devold et al., 2001). How-
ever, these two motifs were not clearly homologous to
each other and could thus not be subjected to meaning-
ful comparison in phylogenetic analysis. Consequently,
we did not force them to align, but rather pulled them
apart. A striking picture emerged (Figs. 1 and 2), with a
strong European ISAV consensus sequence, in which
almost every sequence had a longer or shorter gap at
some point within the PR. That point mutations were not
the major contributor to the polymorphism was further
emphasized by the sharing of a “signature motif” very
similar to one of the European ones, with the genetically
more distant Canadian main group. This supports the
notion that the two signature motifs are nonhomologous,
i.e., they have not evolved from one common ancestral
sequence motif.
The PR lies in a predicted hydrophilic part of the
putative ectodomain, juxtaposed to a hydrophobic, pre-
sumably transmembrane, domain. According to this
model, the PR, which includes the two predicted glyco-
sylation sites of the Glesvaer strain (amino acids 333 and
349), lies in the “stem” of the molecule, immediately
outside the viral envelope.
Sequences of RT-PCR products from three of nine
samples from which no cell culture isolates were ob-
tained revealed the presence of two, and in one case
three, clearly different PR variant sequences in the same
sample (Table 1), i.e., Vir 22 (PR 3 and 12), Vir 24 (PR 4,
6, and 16), and Vir 31 (PR 4 and 6). The cloning and
sequencing of 10–20 separate clones of each variant
excluded the possibility of this being a PCR artifact.
The polymorphic region
The strong similarity of nucleotide sequences be-
tween most sequences allowed quite precise positioning
of the gaps in the PR (Fig. 1). A few nucleotides could,
however, be placed equally well on either side of the gap
in a large number of sequences, suggesting that dele-
tions often had occurred between sites with a similar
sequence.
The variability stretched over a 130-nucleotide region
(Figs. 1 and 2). The placement of the two signature
motifs IRVDAIPPQLNQTFNT and FNTNQVEQPATSVLSNI
(Devold et al., 2001), side by side in the alignment, re-
flects our view that the presence of only one of these
motifs in a given virus is the result of deletion of part of
a longer ancestral sequence, perhaps represented by
the full-length European consensus.
The sequential order of the alignment was determined
by a 10-nucleotide overlap between the left-hand border
of the gap in AF364888 and the right-hand border in Vir
22, 25, 24A, and 28.
The first PR variant motif contains the putative N-linked
glycosylation site NQT. Most PR variants with this motif
have two glycosylation sites in the PR. The other putative
glycosylation site, NIT, was present in all sequences,
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FIG. 2. Amino acid alignment of the polymorphic region. The putative N-linked glycosylation sites are in bold letters. The PR variant of each
sequence is listed to the right. Norwegian county abbreviations: Fi, Finnmark; TR, Troms; NL, Nordland; NT, Nord-Trøndelag; ST, Sør-Trøndelag; MR,
Møre and Romsdal; SF, Sogn and Fjordane; Ho, Hordaland; Ro, Rogaland. Position numbering up to position 351 is according to the Glesvaer
prototype strain.
382 MJAALAND ET AL.
except the members of PR variant 13, which contains
neither one.
Phylogenetic analysis
As observed by Kibenge and co-workers (2001), phy-
logenetic reconstructions covering most of the HA-en-
coding ORF divided the sequences into two statistically
well-supported groups (Fig. 3a): the European clade,
having one Canadian isolate as an outlier; and the main
Canadian clade. Apart from the single European-like
Canadian outlier sequence, the topology of the trees
within these main groups was less well defined (Fig. 3b).
The relatively low number of substitutions in the shorter
sequences surrounding the PR (Glesvaer pos. 959-1153)
was further restricted by the presence of a gap in one or
more sequences over a large portion of the region. As
adequate evolutionary models for insertions and dele-
tions are lacking, these positions were excluded from the
phylogenetic analysis, and the remaining variability was
considered insufficient for phylogenetic reconstruction.
Gap patterns were shared also between some European
sequences and the distant Canadian main clade, em-
phasizing that gap pattern was of limited value as a
measure of genetic relatedness.
Disease development pattern related to PR variants
and epidemiology
Although several intermediate forms were found, the
diseases patterns could roughly be divided into two main
forms—acute or protracted. About half of the PR variants
originated from outbreaks with acute disease develop-
ment, the rest originated from outbreaks with protracted
disease development or from farms with lack of disease
signs.
From the acute disease outbreaks used in this study,
virus was isolated from all samples, while isolation was
successful in four of nine in protracted ISA, and no virus
was isolated from samples from farms without clinical
signs. Two sequences, from farms without ISA, grouped
together with genotypes resulting in acute disease de-
velopment (PR 4). In one (PR 10), both acute and pro-
tracted disease development were represented. Epide-
TABLE 1
The PR Variant Assignments of the ISAV Hemagglutinin Sequences Mapped in This Study Related to Disease Development Patterns
Isolate
year 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Gaps/disease
development
PR1
PR2 Vir5 Vir3 (Canada) 20 aa
A
PR3 Vir7 Vir22B
Vir23
Vir30
17 aa
P
PR4 Vir6/Glesvaer Vir2 Vir24C
Vir11
Vir20 Vir31B 20 aa
A/P
PR5
PR6 Vir21
Selje
Vir24B Vir29
Vir31A
21 aa
P
PR7 Vir4 18 aa
A
PR8 Vir10 Vir8 17 aa
P
PR9
PR10 Vir12
Vir15
Vir16
11 aa
P/A
PR11 Vir13 Vir14
Vir18
11 aa
A
PR12 Vir22A Vir25 8 aa
P
PR13
PR14 Vir9 Vir17 Scotland
Vir19
23 aa
A
PR15 Vir1 Vir26 Vir27 21 aa
A
PR16 Vir28 Vir24A 21 aa
(13 8)
P
Note. Italic  protracted disease development; bold  acute disease development.
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miologically, this group is linked to the PR variant 11
containing acute disease cases (Tables 1 and 2), as
contamination between farms was suspected: an ISA
outbreak at one farm (Vir 15; PR 10) four years earlier, and
contact between this farm and the Vir 16 farm (PR 11),
was confirmed. Furthermore, the disease problems at
the Vir 12 farm (PR 10) were assumed to be caused by
contamination associated with slaughter procedures.
The members of these two variants do, however, cluster
on clearly separate branches of the phylogenetic tree
and thus contradict their assumed epidemiologic link
(Fig. 3b).
Most of the tissue samples came from ISA outbreaks
in separate geographical regions with no known epide-
miologic links. In PR variant 4, Vir 11 and 20 were pre-
sumably connected, as the samples arose from the same
farm and the restrictions on the farm had not been lifted
between the outbreak episodes. In contrast, the third
sequence (Vir 31B) in this group came from a farm with
no history of ISA and with no apparent epidemiologic link
to the other two. Furthermore, a possible epidemiologic
link between Vir 7 (PR 3) and Vir 10 (PR 8), through
contamination of the Vir 10 location after transport of fish
food from the Vir 7-location, found no direct support in
the molecular data. On the other hand, a close epidemi-
ologic link was supported within PR variant 8, as these
sequences were identical. These outbreaks arose in the
same location, although not from the same year, and
were recorded as two separate disease outbreaks.
The contamination of Vir 24 (PR variants 4, 6, 16) could
be a result of a co-operational management between this
location and Vir 25 (PR 12). With the data presently
available, the possibility that Vir 25 is ancestral to Vir 24A
and Vir 28 (both PR 16) cannot be excluded.
Replication in SHK-1 cells
The ISAV isolates used for comparison of quantitative
in vitro replication in the SHK-1 cell line are shown in
Table 3, and the time course of virus production in cell
culture using an infectious dose of 103 TCID50 is shown
in Fig. 4. The first signs of CPE could be observed at day
7 postinfection (p.i.) in cultures inoculated with Vir 6 (PR
4), Vir 7 (PR 3), and Vir 17 (PR 14) (data not shown). CPE
was fully developed at day 10 p.i. in these cultures.
Indications of CPE were observed for Vir 1 (PR 15), Vir 12
(PR 10), and Vir 13 (PR 11) at day 7 p.i. and full CPE was
first observed at days 11–14 p.i.. Development of CPE in
cultures with Vir 4 (PR 7) occurred slowly and was man-
ifested at day 11 p.i. At day 14 p.i., approximately the
same virus titers were obtained from all isolates. At this
time, CPE was fully developed in the cultures and inac-
tivation of the virus may have been initiated.
Another experiment using an infectious dose of 102
TCID50 showed similar results.
DISCUSSION
The present data supplement, and thus expand, exist-
ing knowledge about the heterogeneity within the PR of
the hemagglutinin-encoding genomic segment of ISAV.
FIG. 3. Phylogenetic reconstruction of ISAV HA sequences. Phylogeny of representative sequences based on the entire HA ORF. (a) The inset shows
the distance from the European ISAV clade, with its Canadian outlier sequence, to the main Canadian ISAV clade. (b) Positions in the polymorphic
region where one or more sequences contain a gap were excluded from the analysis. For the branches on the tree that were statistically supported
by bootstrap analysis, scores are given.
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The presence of multiple virus strains in some of the
ISA-affected farms is confirmed, and a simple model
accounting for all the variants is proposed. The polymor-
phism is characterized by the presence of gaps more
than by increased occurrence of single-nucleotide sub-
stitutions, and the existence of gaps in practically every
sequence, strictly confined to this short variable region,
is striking. The assignment of HA in groups based on PR
variants was to some extent in agreement with the as-
sumed clustering of outbreaks. However, in several in-
stances it seems more likely that identical substitutions
or gaps had arisen independently, and, that in some
cases, related viruses in the same outbreak environment
had diverged by acquiring different deletions. The pres-
ence of many distinct gap patterns in otherwise highly
similar sequences are strongly suggestive of several
independent, and relatively recent, deletion, rather than
insertion, events.
The polymorphic region of the hitherto longest ISAV
HA gene reported (Kibenge et al., 2001) is one amino
acid longer than the two longest observed in this study.
The two signature motifs which have been used to clas-
sify the European viruses into two groups (Devold et al.,
2001) are not clearly homologous, and it is conceivable
that both may have existed side by side in an ancestral
sequence. The concept of a longer ancestral sequence
TABLE 2
Molecular and Epidemiological Features of the PR Variants
PR
variant Molecular and epidemiological characteristics
1 The left-hand border of the 51-nt gap of this variant overlaps with the right-hand border of variants 12 and 16.
2 The 60-nt gap interferes with the flanking F and M codons which are joined into a TTG L codon. No full-length sequences available.
Two strains from Sogn og Fjordane, W Norway, as well as one from Canada.
3 Five strains from Nordland, N Norway, and one Canadian.
4 The 60-nt gap is shifted three bases upstream compared to variant 2, interfering with flanking F and I codons and generating a new
ACA T codon, thus preserving a putative NQT glycosylation site. Full-length representatives cluster at two different positions in the
phylogenetic tree and can be divided into one group with Northern Norway strains and the remainder in one group having
representatives from Western Norway, Northern Norway, and, although slightly divergent, Scotland. Vir 31B originated from a
recent SW Norway sample which also contains another sequence (Vir31A) belonging to variant 6; these two are not available as
full-length sequences. The N Norway Vir 24 sample revealed three distinct viral sequences each belonging to separate variants:
Vir 24C (this variant), Vir 24B (variant 6), and Vir 24A (variant 16); combined they cover the entire proposed European ancestral
sequence.
5 Two strains from W and NW Norway, respectively. Do not cluster together in phylogenetic analysis.
6 Members of this variant originate from NW, W, and SW Norway, as well as from England. No full-length sequences available for
phylogenetic analysis. The Vir 31 material yielded two different sequences, the other matching variant 4.
7 One single member, comparably divergent in phylogenetic analysis.
8 Four strains from Troms, N Norway. The two full-length HA sequences cluster together in phylogenetic analysis.
9 Two strains from Sogn og Fjordane, W Norway, clustering together in phylogenetic analysis. The deletion interferes with flanking Q
and S codons, generating a new CGC R codon.
10
11
Although contamination between farms were suspected between members of variant 10 and 11 outbreaks, this was not supported
by sequence analysis. The 33-nt gap of these groups appears shifted relative to each other, but, alternatively, an identical gap
position plus an additional nonsilent substitution in one of the variants could have occurred. The full-length representatives of the
two variants do, however, cluster differently in the tree and the variant 10 and 11 outbreaks are therefore most likely not
connected epidemiologically. The genetic distance between the two variants may be underestimated, as further two variant 11
substitutions compared to variant 10 were eclipsed in the phylogenetic analysis by gaps in other sequences.
12 This variant has the longest variable region of the European sequences observed in this study, but still lacks 24 nucleotides
compared to the proposed ancestral sequence. Both members from same county, consecutive years. The Vir 22 material yielded
two different sequences, the other matching variant 3. Together they cover the entire European consensus. Full-length sequences
not available.
13 One strain from Møre og Romsdal, NW Norway, clustering together with a well-separated clade containing variant 11 strains from
neighboring Sør-Trøndelag county, as well as one strain from N Norway belonging to variant 14.
14 Contains a 57-nt gap, the longest continuous gap seen in the presently analyzed sequences. While the majority of the strains
originate from Western Norway, representatives from Northern Norway and Scotland are also present. Most of the Western
Norway full-length sequences cluster together in phylogenetic analysis, while the others are more scattered on the tree.
15 All members are from Hordaland county, 1987–1993. The three full-length sequences of this variant cluster together in phylogenetic
analysis. An epidemiological connection is likely.
16 Two gaps present, the left-hand one more distal to the putative transmembrane region than the other gaps. Consequently, these
sequences lacks both putative N-glycosylation sites. The coincidence of the two-gap pattern in these two Northern Norway
sequences is suggestive of an epidemiological connection. If the three sequences in the Vir24 sample are monophyletic, the Vir28
virus, although an older sample, is probably derived from the former and not vice versa.
17 This variant is represented by the longest published Canadian main group isolate and is seven amino acids shorter than the
European full-length consensus.
18 This variant, similar to PR variant 8 but slightly different at the nucleic acid level, is present in the majority of Canadian isolates.
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is consistent with the considerably longer HA homo-
logues of the established terrestrial orthomyxoviruses.
The more distant Canadian sequences containing a sig-
nature motif closely related to one of the European se-
quences demonstrates that this region is not a hot spot
for point mutations, and the conclusions drawn by
Devold and co-workers are thus contradicted (Devold et
al., 2001). A putative ancestral HA sequence was recon-
structed, using “side-by-side” presentation of the signa-
ture motifs, together with the present data containing
sufficient overlapping sequences. All the European PR
variants can be explained by deletions from this pro-
posed conserved, ancestral, sequence. During the prep-
aration of this article, a partial polymorphic region se-
quence from wild Atlantic salmon in Scotland has been
sequenced (C. Cunningham, personal communication).
The long PR in this sequence coincides with the pro-
posed ancestral sequence, and thus, with our differential
deletion hypothesis. The independent occurrence of sim-
ilar deletions in practically every ISAV strain is sugges-
tive of parallel evolution in face of a common strong
functional selective pressure.
The existence of coinfection was demonstrated by the
fact that fish from several ISA-affected farms harbored
multiple ISAV HA sequences. Coinfections are an abso-
lute requirement for reassortment and recombination to
occur and contribute to variability. The different combi-
nations of sequence motifs observed in the PR have
previously been interpreted as a result of homologous
recombination (Devold et al., 2001). There is, however, a
lack of firm evidence for homologous recombination in
negative-strand RNA viruses (Webster, 2001). As dele-
tions are a quite firmly established trait of this HA gene
region, we assume the alternative explanation of differ-
ential deletion from an even longer donor virus gene
harboring both signature motifs is more likely. This
TABLE 3
ISAV Viruses/Samples Used in This Study
Strain/sample designation
Geographic location by county
(Norway) or country Year
Isolation in
cell culture
*Vir 1:/89 (Bolaks; AF 427043) Hordaland 1989 
*Vir 4: H2143/89 (Torris; AF 427046) Nordland 
Vir 6: 90/09/400  Glesvaer/2/90 (AF 427048) Hordaland 1990 

Vir 2: 91/09/2397 (Mowi; AF 427044) Hordaland 1991 
Vir 26: B-162/92 (Mowi-AN92; AF 427071) Hordaland 1992 
*Vir 7: 93/09/2163 (Lofoten Salmon; AF 427049) Nordland 1993 
Vir 10: 93/09/2264 (Gullesfjord; AF 427052) Troms 
Vir 27: B-797/93 (Mowi-AN93; AF 427072) Hordaland 
Vir 8: 94/09/661 (Gullesfjord; AF 427050) Troms 1994 
Vir 28: 94/09/579 (Nye Meridianlaks; AF 427073) Finnmark 
Vir 21: 95/09/720 (Haukå; AF 427063) Sogn og Fjordane 1995 
Selje 95/09/1525 (AF 427078) Sogn og Fjordane 
Vir 5: 96/09/734 (Landøy; AF 427047) Sogn og Fjordane 1996 
Vir 9: 96/09/768 (Eide; AF 427051) Hordaland 
Vir 11: 96/09/1729 (Senja laks; AF 427053) Troms 
*Vir 13: 96/09/1712 (Hitra Laks; AF 427055) Sør-Trøndelag 
Vir 22: 96/09/724 (Husvågan; AF 427064; AF 427065) Nordland ?/
Vir 23: 96/09/718 (Grylseth; AF 427066) Nordland 
Vir 24: 96/09/873 (Oddlaks; AF 427067; AF 427068; AF 427069) Nordland 
Vir 30: 96/09/700 (Grylseth; AF 427075)
Vir 3: F1–97 (AF 427045) Canada 1997 
*Vir 12: 97/09/615 (Måsøval; AF 427054) Sør-Trøndelag 
Vir 14: 97/09/1068 (Stjernefisken; AF 427056) Sør-Trøndelag 
Vir 15: 97/09/1825 (Salmar; AF 427057) Sør-Trøndelag  (3/10)
Vir 16: 97/09/1853 (Farmo; AF 427058) Sør-Trøndelag  (2/10)
*Vir 17:97/09/1875 (Torgnes; AF 427059) Nordland  (1/10)
Vir 18:97/09/1892 (Astor; AF 427060) Sør-Trøndelag  (5/5)
Vir 25: 97/09/393 (PundslettII; AF 427070) Nordland 
Vir 19: 98/09/16 (Fjordlaks; AF 427061) Nordland 1998  (5/10)
Vir 20: 98/09/142 (Senja; AF 427062) Troms  (4/6)
390/98 (AJ276859) Scotland 
Vir 29: GM-99/1 (AF 427074) Cumberland; England 1999 
Vir 31: GM-99/2 (AF 427076; AF 427077) Rogaland 
Note. The ISAV samples were tested for their ability to replicate in the SHK-1 cell line.
* Isolates selected for comparative quantitative in vitro replication in the SHK-1 cell line.
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model makes it unnecessary to postulate different viral
ancestors for the multiple PR variants seen in some
locations. Our assumption is further strengthened by the
corresponding occurrence of different signature motifs
seen among the otherwise comparably uniform Cana-
dian clade (Kibenge et al., 2001) and also found in the
sequence from wild Atlantic salmon (C. Cunningham,
personal communication).
Cultivation of ISAV from different PR variants in SHK-1
cells revealed differences in ability to replicate. For nine
of the affected farms, of which four had an ISA diagnosis,
attempts of virus isolation were unsuccessful. This fail-
ure to isolate virus may reflect that the SHK-1 cell line is
not permissive for all ISAV strains. In fact, differences in
cell-culture susceptibility between ISAV strains have
been reported (Kibenge et al., 2000), where a 3-terminal
sequence insertion/deletion in the HA gene in one strain
is suggested to cause a change in receptor avidity (Grif-
fiths et al., 2001). Furthermore, in influenza A, balanced
HA-NA functions have been shown to be necessary for
efficient virus replication, where mutations in HA ap-
peared as a compensation for reduced NA function due
to stalk deletion (Mitnaul et al., 2000). However, in a
recent study, no clear association between virulence of
the virus in tissue culture and sequence variation in the
HA gene was found (Kibenge et al., 2001).
There are variations in the rate of replication in SHK-1
cells between representatives from selected ISAV PR
variants. However, no clear correlation between replica-
tion properties in SHK-1 cells and the development of
CPE was found. For example, the isolate from PR variant
4 (Vir 6) showed the highest replication rate and a CPE
was observed early, while the isolate from PR 11 (Vir 13)
also replicated well in cell culture but CPE appeared
much later. Furthermore, virus isolates from acute out-
breaks showed great differences in their replication rate
in SHK-1 cells, e.g., isolates from PR 4 (Vir 6) and PR 7
(Vir 4). Thus variation in replication rate could be a result
of selective adaptation to the SHK-1 cell line. Cocircula-
tion of multiple ISAV strains in an outbreak may be more
common than the present data indicate. If some virus
strains are more prone to propagation in SHK-1 cells,
they would preferentially be detected.
The polymorphism in the HA polypeptide does indeed
affect the assumed glycosylation pattern; as in 67% of the
new sequences in this study, one of the two predicted
sites is absent, and in one PR variant (PR 16) both sites
have been deleted. Glycosylation of the ISAV HA mole-
cule has been confirmed by deglycosylation studies
(Griffiths et al., 2001). The only two predicted N-linked
glycosylation sites of this molecule, compared to three to
seven in influenza A, occur in the variable region of the
ectodomain, and it can be assumed that this is no coin-
cidence. Although no vital function is known for the
carbohydrate moieties on the mature influenza A HA
protein, addition of carbohydrate is pivotal for the correct
folding of HA in the ER (Braakman and van Anken, 2000;
Sugahara et al., 2001). Oligosaccharides located in close
vicinity to the receptor-binding pocket have been shown
to influence receptor-binding affinity, thus having a pro-
nounced effect on virus production in mammalian cells
(Ohuchi et al., 1997). Furthermore, glycosylation of HA
and stalk length of the neuraminidase combine to regu-
late the growth of avian influenza viruses (Baigent and
McCauley, 2001). The location of the receptor-binding
site on the ISAV HA molecule and the variability in the
ISAV receptor destroying enzyme is, at present, un-
known. Hence, the possible effects of differences in
glycosylation patterns are not predictable. It should in
that connection be noted, however, that in the in vitro
replication studies the isolates inhabiting two putative
glycosylation sites—one representing the acute disease
development (Vir 6; PR 4) and one representing the
protracted disease course (Vir 7; PR 3)—are the ones
giving the highest replication rate in the SHK-1 cell line
within their group.
Most of the sequences belonging to a given PR variant
derived from outbreaks with similar disease develop-
ment. For instance, Vir 29 and Vir 31, that originated from
farms with no history of ISA, belonged to HA PR variants
in which the other members were isolated from ISA
outbreaks with a slow disease development. For some
PR variants, though, e.g., 4, 6, and 10, this correlation was
less obvious. Whether the polymorphic region of the ISAV
HA is related to a virulence pattern is uncertain, since the
number of isolates in this study was limited, and the
nature of disease development is complex, involving
viral, host, and environmental factors.
The observed variation in the ISAV HA gene could, in
principle, be selected by a host immune response. How-
ever, in farmed Atlantic salmon populations, there is little
FIG. 4. Replication of selected ISAV isolates in SHK-1 cells. Virus
titers in cell-culture medium were determined at the indicated time
points. F, Vir 1 (PR 15); f, Vir 4 (PR 7); ‚, Vir 6 (PR 4); Œ, Vir 7 (PR 3);
*, Vir 12 (PR 10); , Vir 13 (PR 11); E, Vir 17 (PR 14). Solid line: isolates
from acute disease outbreaks; dotted line: isolates from protracted
disease outbreaks.
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or no contact between the different generations of fish,
and in Norway no vaccination against ISA is being done
at present. The selection pressure caused by preimmu-
nity of the population must thus be small, and the con-
tribution of antibody-mediated selection pressures is
probably less important than for the influenza viruses.
The polymorphism located in the stem of the molecule
would probably not be very accessible for antibodies.
The modest variability in the globular head of the ISAV
HA molecule may well be constrained by stabilizing
selection, and the deletions in the stem of the molecule
may have arisen under strong functional selection.
Sea-cage farming of Atlantic salmon on an industrial
scale had existed for nearly two decades before ISA was
recognized as a disease entity. Our findings, where the
emergence of ISA disease in some sea farms may have
no connections to other outbreaks, together with the lack
of disease in pure freshwater farms, suggest that wild
fish could be the infectious source. This possibility is
becoming even more likely with the mounting evidence
for the presence of ISAV in wild fish (Raynard et al., 2001).
The observed variation could thus be analogous to influ-
enza viruses, which under some circumstances tend to
adapt through genetic changes that include deletions
and possibly also insertions. Influenza A NA stalk dele-
tions have been observed in instances where reassort-
ment and cross-species transfer have occurred (Hughes
et al., 2001), e.g., the H5N1 1997 Hong Kong “chicken flu”
virus (Claas et al., 1998). The observed variations in the
stem of the ISAV HA molecule could be a result of
cross-species transfer events, in which loss of fitness in
a new environment is relieved through HA stalk dele-
tions. Alternatively, a wild-type salmon virus might mu-
tate as a consequence of alterations in the ecological
niche: in a densely populated net pen environment, more
frequent transmission opportunities may reward more
virulent virus phenotypes, which otherwise would suc-
cumb together with their sick host individual in a natural
environment.
In conclusion, the European ISAV HA sequences could
be put into genogroups based on gap patterns superim-
posed on a longer and quite conserved consensus se-
quence, as if they had arisen from similar and longer
ancestral sequences through parallel independent and
recent deletion events. Nine of thirty-three samples did
not yield ISAV that would replicate in the SHK-1 cell line,
and there was a difference in in vitro replication proper-
ties between genogroups. In samples from three farms,
multiple ISAV PR variants were detected. As most se-
quences belonging to a given PR variant derived from
outbreaks with similar disease development, the PR re-
gion could possibly be related to a virulence pattern. Due
to the frequent occurrence of identical mutations in dif-
ferent genetic lineages, as well as dramatic differences
between viruses likely to be closely related, we do not
consider that the PR alone contains reliable information
for inferring the genetic relationships among the ISA
viruses.
The farming of salmonids in seawater with high den-
sities of single fish species, combined with exposure to
infectious agents present in the environment, has pro-
duced favorable conditions for the adaptation and am-
plification of pathogens. The present data indicate that
the European ISA outbreaks may have been the result of
several independent introductions of virus into farmed
Atlantic salmon from wild fish, followed by parallel ad-
aptation to the new host organism through hemaggluti-
nin gene deletions. One prediction from such a hypoth-
esis is that the wild fish donor strains should have a
longer homolog of the hypervariable region, containing
all the different sequence motifs. Another prediction is
that such “wild” viruses are expected to be less fit than
the outbreak-associated viruses in the sea-cage setting.
Furthermore, the findings of ISAV sequences in fish from
farms without ISA outbreaks may suggest that, in some
cases, adaptive mutation of an already present virus,
rather than the introduction of a pathogenic virus, is the
decisive triggering factor in disease outbreak develop-
ment, and that this process of virus adaptation is still
going on. The more uniform sequence patterns seen in
the main Canadian clade (Kibenge et al., 2001) may
indicate that the ecology of those viruses differs from the
European ones, perhaps arising from a single more re-
cent common source and to a larger extent being the
result of either spreading between facilities or circulation
of the same variant in a wild host. Further studies of
these viruses including their interactions with different
host species are needed.
MATERIALS AND METHODS
ISAV isolates/samples
ISA outbreaks in Norway from the time period 1989–
1999 were selected for analysis (Table 3). Twenty-four
sequences from separate ISA outbreaks from which vi-
ruses had been isolated in cell culture, seven sequences
from farms with disease problems but no verified ISA
diagnosis, and two sequences from farms with no history
of ISA (Vir 29 (England) and Vir 31 (Rogaland)) were
analyzed. However, ISAV-specific reverse transcription
(RT)-PCR reactions performed on RNA extracted from
kidney samples from these nine farms proved positive
and were thus included in this study, in addition to one
isolate each from Scotland (No. AJ276859) and Canada
(No. AF427045). A selected number of already published
Canadian, Scottish, and Norwegian ISAV HA sequences
were included in a summarizing sequence alignment
(accession numbers included in Fig. 1).
Descriptions of the developments in the different dis-
ease outbreaks were obtained from the Norwegian An-
imal Health Authority and veterinarians responsible for
the disease surveillance in affected fish farms. The cat-
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egorization of disease outbreaks into “acute” and “pro-
tracted” was a simplification. Transitional forms were
often present.
Cells
Salmon head kidney cells (SHK-1 cells) grown at 20°C
as described earlier (Dannevig et al., 1995) were used for
cultivation of ISAV.
Virus isolation and identification
Kidney tissue collected from ISA outbreaks was ho-
mogenized (10%, w/v) and used directly for inoculation
onto SHK-1 cells or stored at 80°C until inoculation.
Cells inoculated with virus were incubated at 15°C for
4 h. Following removal of the inoculate, fully supple-
mented Leibowitz (L-15) medium was added, and the
cultures incubated for 1–2 weeks, being regularly in-
spected for development of cytopathic effect (CPE). Cul-
ture supernatants were passaged once (or in some in-
stances twice), and the final supernatants were har-
vested for identification of virus and thereafter stored at
80°C.
ISAV was identified using an indirect immunofluores-
cence test (Falk et al., 1998) and examined in an inverted
fluorescence microscope.
Viral replication and quantification
A comparison of the development of CPE and time
course of virus production in cell culture between seven
of the identified PR variants was performed. Only vari-
ants where virus had been isolated could be tested,
excluding variant 12 and 16. The ones selected for anal-
ysis were as follows: Vir 7 (PR 3), Glesvaer/Vir 6 (PR 4),
and Vir 4 (PR 7), Vir 12 (PR 10), Vir 13 (PR 11), Vir 17 (PR
14), and Vir 1 (PR 15).
SHK-1 cells in 25-cm2 flasks were inoculated with
supernatants from the third passage containing 102 or
103 tissue-culture infective doses (TCID50/ml) of the dif-
ferent ISAV strains. The cell cultures were inspected
daily for CPE. Aliquots of the culture medium were re-
moved at days 4, 7, 11, and 14 for determination of virus
titer.
Virus titers were determined by measuring the
TCID50/ml by end-point titration in 96-well culture plates
with SHK-1 cells using fivefold serial dilution and four
parallels per dilution (Ka¨rber, 1931). After 1 week’s incu-
bation, the cells were fixed and stained for ISAV as
described above.
RT-PCR and molecular cloning
Total RNA was extracted from ISAV-infected SHK-1
cells using the TRIzol Reagent (Gibco-BRL, Gaithersburg,
MD) as described by the manufacturer. Two pairs of PCR
primers from the HA-encoding genomic segment from
the Glesvaer isolate were designed. Primer pair 1: Vir-F1
(5-TGAGGGAGGTAGCATTGCAT-3) and Vir-R1 (5-AAG-
CAACAGACAGGCTCGAT -3) was designed from posi-
tions 957 to 1181, giving an approximately 225-bp prod-
uct, including the polymorphic region of the segment,
and was used in all the RT-PCR reactions. The second
primer pair, Klon1EGFP-F1 (5-GGGCTAGCATGGCAC-
GATTCATAATT -3) and Klon1EGFP-R1 (5-GGGGTACCG-
TAGCAACAGACAGGCTCGAT-3, encompassing the HA
ORF from positions 11 to 1181, was used for Vir 1, Vir 4,
Glesvaer (Vir 6), Scotland 390/98, Vir 10, Vir 16, Vir 18, and
Vir 28.
RT-PCR was performed as described earlier (Mikalsen
et al., 2001). The tubes were incubated at 94°C for 5 min,
followed by 35 cycles of 94°C for 30 s, 55°C for 15 s,
72°C for 30 s (short polymorphic sequences) or alterna-
tively 72°C for 60 s (full ORF sequences), and a final
extension at 72°C for 7 min.
Amplified DNA was cloned in the vector pCR-2.1 using
a TOPO-cloning kit (Invitrogen, Leek, The Netherlands)
according to the user instructions.
Nucleotide sequencing and computer analysis
Molecular clones were sequenced using an ABI
PRISM Big Dye Terminator Cycle Sequencing kit in an
automatic sequencer (ABI Prism 377; Foster City, CA).
Ten to twenty clones from each isolate were sequenced
for verification. The sequences were analyzed using Vec-
tor NTI Suite 6 Programme (Informax Inc., North Be-
thesda, MD). The Norwegian isolate Glesvaer/2/90 (Ac-
cession No. AF220607) is the prototype Norwegian ISAV
strain (Mjaaland et al., 1997), and subsequent nucleotide
and amino acid positions refer to this strain. Alignments
of nucleotide and amino acid sequences were carried
out using the BLAST (Altschul et al., 1997) and Clustal W
programs (Thompson et al., 1994). Manual adjustments
in the polymorphic region were made with the BioEdit
alignment editor (Hall, 1999), and distance-based phylo-
genetic analysis was performed using PAUP 4.0b8 (Swof-
ford, 1998), making use of the HK85 substitution model.
Only the portions of alignments that contained no se-
quence gaps were included in this analysis. For the
prediction of transmembrane regions the TopPred 2 Pro-
gramme (von Heijne, 1992) was used.
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